Summary
L-deprenyl, a specific MAO-B inhibitor, has been proposed to possess a neuroprotective effect. The mechanism of such an effect is unclear. L-Deprenyl has been found to increase rat striatal Superoxide dismutase (SOD) activity, which inactivates singlet oxygen. It would be very interesting to know how such activation occurs and whether or not other MAO inhibitors also have such an effect. We have analyzed rat striatal SOD activity using a very sensitive nitrite method and an immunological procedure. The effect of different doses and time of treatment with 1-deprenyl and M-2-PP (2-pentyl-N-methyl-propargylamine), a new highly potent, selective and non-amphetamine-like MAO-B inhibitor, on the rat brain has been investigated. We were unable to detect any increase of SOD activity in the rat striata and cerebral cortex nor any increase in the concentration of immunoreactive SOD antibody in the cortex following chronic treatment with 1-deprenyl and M-2-PP. It remains to be substantiated as to whether or not 1-deprenyl can enhance SOD levels.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Carrillo MC, Kanai S, Nokubo, Kitani K (1991) (-)-Deprenyl induces activities of both Superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. Life Sci 48: 517–521.
Carrillo MC, Kitani K, Kanai S, Sato Y, Ivy GO (1992) The ability of (-)-deprenyl to increase Superoxide dismutase activities in the rat tissue and brain region selective. Life Sci 50: 1985–1992.
Ceballos I, Lafon M, Agid J, Hirsch F, Nicole A, Sinet PM, Agid Y (1990) Superoxide dismutase and Parkinson’s disease. Lancet i: 1035–1036.
Clow A, Hussain T, Glover V, Sandier M, Dexter DT, Walker M (1990) (−)-Deprenyl can induce soluble Superoxide dismutase in rat striata. J Neural Transm [Gen Sect] 86: 77–80.
Cohen G (1983) The pathobiolobgy of Parkinson’s disease: biochemical aspects of dopamine neuron senescence. J Neural Transm [Suppl] 19: 98–103.
Colton CA, Gilbert DL (1987) Production of Superoxide anions by a CNS macrophage, the microglia. FEBS Lett 223: 284–288.
Curnutte JT, Babior BM (1987) Chronic granulomatous disease. Adv Hum Genet 16: 229–297.
Dexter DT, Carter CJ, Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD (1986) Lipid peroxidation as cause of nigral cell death in Parkinson’s disease. Lancet: 639-640.
Dexter DT, Carter CJ, Wells FR, Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD (1989a) Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease. J Neurochem 52: 381–389.
Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989b) Increased nigra iron content and alternations in other metal ions occuring in brain in Parkinson’s disease. J Neurochem 52: 1830–1836.
Frank L (1982) Protection from O2 toxicity by pre-exposure to hypoxia: lung anti-oxidant enzyme role. J Appl Physiol 53: 475–482.
Hirsch EC, Brandel J-P, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson’s disease: an X-ray microanalysis. J Neurochem 56: 446–451.
Knoll J (1988) The striatal dopamine dependency of lifespan in male rats. Longevity study with (—)deprenyl. Mech Ageing Dev 46: 237–262.
Knoll J, Dallo J, Yen TT (1989) Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (—)deprenyl. Life Sci 45: 525–531.
Kramer K, Voss HP, Grimbergen JA, Timmerman H, Bast A (1987) The effect of ischemia and recirculation, hypoxia and recovery on anti-oxidant factors and ß-adrenoceptor density. Biochem Biophys Res Commun 149: 568–575.
Marttila RJ, Lorenz H, Rinne UK (1988) Oxygen toxicity protecting enzymes in Parkinson’s disease. Increase of Superoxide dismutase-like activity in the substantia nigra and basal nucleus. J Neurol Sci 86: 321–331.
Marttila RJ, Viljanen M, Toivonen E, Lorentz H, Rinne UK (1990) Superoxide dismutase-like activity in the Parkinson’s disease brain. Adv Neurol 53: 141–144.
McCord JM, Fridorich I (1969) Superoxide dismutase. An enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049–6055.
Milgram NW, Racine RJ, Nellis P, Mendonca A, Ivy GO (1990) Maintenance on L-deprenyl prolongs life in aged male rats. Life Sci 47: 415–420.
Oyanagui Y (1984) Réévaluation of assay methods and establishment of kit for Superoxide dismutase activity. Anal Biochem 142: 290–296.
The Parkinson Study Group (1989) Effect of deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med 321: 1364–1371.
Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in par-kinsonian brains. J Neurochem 52: 515–520.
Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD (1989) A selective increase in particulate Superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 53: 692–697.
Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MBH (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 74: 199–205.
Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MBH (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56: 978–982.
Tetrud JW, Langston JW (1989) The effect of deprenyl (Selegiline) on the natural history of Parkinson’s disease. Science 245: 519–522.
Wilkinson GN (1961) Statistical estimation in enzyme kinetics. Biochem J 80: 324–332.
Yu PH, Davis BA, Boulton AA (1992) Neuronal and astroglial monoamine oxidase: pharmacological implications of specific MAO-B inhibitors. Prog Brain Res 94: 309–315.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag
About this paper
Cite this paper
Lai, C.T., Zuo, D.M., Yu, P.H. (1994). Is brain superoxide dismutase activity increased following chronic treatment with 1-deprenyl?. In: Tipton, K.F., Youdim, M.B.H., Barwell, C.J., Callingham, B.A., Lyles, G.A. (eds) Amine Oxidases: Function and Dysfunction. Journal of Neural Transmission, vol 41. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9324-2_28
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9324-2_28
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82521-1
Online ISBN: 978-3-7091-9324-2
eBook Packages: Springer Book Archive